Nursing Home Agency, Oslo Municipality, Norway.
General Practice Research Unit, Department of General Practice, Institute of Health and Society, University of Oslo, Postbox 1130 Blinderen, N-0318, Oslo, Norway.
BMC Geriatr. 2020 Sep 9;20(1):336. doi: 10.1186/s12877-020-01745-y.
Residents at nursing homes (NHs) are at particular risk for drug related harm. Regular medication reviews using explicit criteria for pharmacological inappropriateness and classification of drug related problems (DRPs) have recently been introduced as measures to improve the quality of medication use and for making the treatment more uniform across different institutions. Knowledge about variation in DRPs between NHs is scarce. To explore if increased attention towards more appropriate drug treatment in NHs have led to more uniform treatment, we have analyzed variations between different nursing homes' drug use and DRPs.
Cross-sectional medication review study including 2465 long-term care residents at 41 NHs in Oslo, Norway. Regular drug use was retrieved from the patients' medical records. DRPs were identified by using STOPP/START and NORGEP criteria and a drug-drug interactions database. NHs were grouped in quartiles based on average levels of drug use. The upper and lower quartiles were compared using independent samples t-test and associations between drug use and DRPs were tested by logistic regression.
Patients' mean age was 85.9 years, 74.2% were women. Mean numbers of regular drugs per patient was 6.8 and varied between NHs from 4.8 to 9.3. The proportion of patients within each NH using psychotropic and analgesic drugs varied largely: antipsychotics from three to 50%, benzodiazepines from 24 to 99%, antidepressants from nine to 75%, anti-dementia drugs from no use to 42%, opioids from no use to 65% and paracetamol from 16 to 74%. Mean DRPs per patient was 2.0 and varied between NHs from 0.5 to 3.4. The quartiles of NHs with highest and lowest mean drugs per patient (7.7 vs. 5.7, p < 0.001) had comparable mean number of DRPs per patient (2.2 vs. 1.8, p = 0.2). Using more drugs and the use of opioids, antipsychotics, benzodiazepines and antidepressants were associated with more DRPs.
The use of psychotropic and analgesic drugs was high and varied substantially between different NHs. Even if the use of more drugs, opioids and psychotropic drugs was associated with DRPs, no difference was found in DRPs between the NHs with highest vs. lowest drug use.
养老院(NHs)的居民特别容易受到药物相关伤害。最近,使用明确的药物不适当性标准和药物相关问题(DRP)分类来定期进行药物审查,作为提高药物使用质量和使治疗在不同机构更加统一的措施。关于 NHs 之间 DRP 差异的知识很少。为了探讨 NHs 对更适当药物治疗的关注是否导致了更统一的治疗,我们分析了不同养老院药物使用和 DRP 的差异。
这是一项横断面药物审查研究,包括挪威奥斯陆 41 家 NHs 的 2465 名长期护理居民。常规药物使用从患者的病历中检索。使用 STOPP/START 和 NORGEP 标准以及药物-药物相互作用数据库来识别 DRP。NHs 根据药物使用的平均水平分为四等份。使用独立样本 t 检验比较上下四分位数,并通过逻辑回归测试药物使用与 DRP 之间的关联。
患者的平均年龄为 85.9 岁,74.2%为女性。每位患者的常规药物数量平均为 6.8 种,NHs 之间的数量从 4.8 种到 9.3 种不等。每个 NH 使用精神药物和止痛药的患者比例差异很大:抗精神病药从 3%到 50%,苯二氮䓬类药物从 24%到 99%,抗抑郁药从 9%到 75%,抗痴呆药从无使用到 42%,阿片类药物从无使用到 65%,扑热息痛从 16%到 74%。每位患者的平均 DRP 为 2.0,NHs 之间的数量从 0.5 到 3.4 不等。药物使用量最高和最低的 NHs 四分位数(7.7 与 5.7,p<0.001)的平均 DRP 数量相似(2.2 与 1.8,p=0.2)。使用更多药物和使用阿片类药物、抗精神病药、苯二氮䓬类药物和抗抑郁药与更多 DRP 相关。
精神药物和止痛药的使用量较高,且在不同 NHs 之间差异很大。即使药物使用量、阿片类药物和精神药物的使用与 DRP 相关,但在药物使用量最高和最低的 NHs 之间,DRP 没有差异。